Skip to main content

and
  1. Article

    Open Access

    Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study

    To compare the adverse events after initiation of nevirapine-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazol...

    Weerawat Manosuthi, Nopphanath Chumpathat, Achara Chaovavanich in BMC Infectious Diseases (2005)